109 related articles for article (PubMed ID: 10960187)
1. 5-(4'-Substituted-2'-nitroanilino)-1,2,3-triazoles as new potential potassium channel activators. I.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Eur J Med Chem; 2000; 35(7-8):715-20. PubMed ID: 10960187
[TBL] [Abstract][Full Text] [Related]
2. 1,5-Diarylsubstituted 1,2,3-triazoles as potassium channel activators. VI.
Biagi G; Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2004 May; 59(5):397-404. PubMed ID: 15120319
[TBL] [Abstract][Full Text] [Related]
3. 1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII.
Calderone V; Giorgi I; Livi O; Martinotti E; Martelli A; Nardi A
Farmaco; 2005 May; 60(5):367-75. PubMed ID: 15910810
[TBL] [Abstract][Full Text] [Related]
4. Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II.
Baragatti B; Biagi G; Calderone V; Giorgi I; Livi O; Martinotti E; Scartoni V
Eur J Med Chem; 2000 Oct; 35(10):949-55. PubMed ID: 11121621
[TBL] [Abstract][Full Text] [Related]
5. Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III.
Biagi G; Calderone V; Giorgi I; Livi O; Scartoni V; Baragatti B; Martinotti E
Farmaco; 2001 Nov; 56(11):841-9. PubMed ID: 11765036
[TBL] [Abstract][Full Text] [Related]
6. Benzoyl and/or benzyl substituted 1,2,3-triazoles as potassium channel activators. VIII.
Calderone V; Giorgi I; Livi O; Martinotti E; Mantuano E; Martelli A; Nardi A
Eur J Med Chem; 2005 Jun; 40(6):521-8. PubMed ID: 15922836
[TBL] [Abstract][Full Text] [Related]
7. Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.
Calderone V; Martelli A; Testai L; Martinotti E; Breschi MC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):73-80. PubMed ID: 17203288
[TBL] [Abstract][Full Text] [Related]
8. Structural modifications of benzanilide derivatives, effective potassium channel openers. X.
Calderone V; Coi A; Fiamingo FL; Giorgi I; Leonardi M; Livi O; Martelli A; Martinotti E
Eur J Med Chem; 2006 Dec; 41(12):1421-9. PubMed ID: 17030483
[TBL] [Abstract][Full Text] [Related]
9. New 5-substituted-1-(2-hydroxybenzoyl)-benzotriazoles, potassium channel activators. IV.
Biagi G; Giorgi I; Livi O; Scartoni V; Barili PL; Calderone V; Martinotti E
Farmaco; 2001 Nov; 56(11):827-34. PubMed ID: 11765034
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V.
Biagi G; Giorgi I; Livi O; Nardi A; Calderone V; Martelli A; Martinotti E; LeRoy Salerni O
Eur J Med Chem; 2004 Jun; 39(6):491-8. PubMed ID: 15183907
[TBL] [Abstract][Full Text] [Related]
11. Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.
Magnon M; Calderone V; Floch A; Cavero I
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):452-63. PubMed ID: 9826068
[TBL] [Abstract][Full Text] [Related]
12. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
13. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries.
Berkan O; Saraç B; Simşek R; Yildirim S; Sarioğlu Y; Safak C
Eur J Med Chem; 2002 Jun; 37(6):519-23. PubMed ID: 12204478
[TBL] [Abstract][Full Text] [Related]
15. 1,4-Benzothiazine ATP-sensitive potassium channel openers: modifications at the C-2 and C-6 positions.
Martelli A; Manfroni G; Sabbatini P; Barreca ML; Testai L; Novelli M; Sabatini S; Massari S; Tabarrini O; Masiello P; Calderone V; Cecchetti V
J Med Chem; 2013 Jun; 56(11):4718-28. PubMed ID: 23662847
[TBL] [Abstract][Full Text] [Related]
16. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
17. Effect on K(ATP) channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides.
Boverie S; Antoine MH; Somers F; Becker B; Sebille S; Ouedraogo R; Counerotte S; Pirotte B; Lebrun P; de Tullio P
J Med Chem; 2005 May; 48(10):3492-503. PubMed ID: 15887958
[TBL] [Abstract][Full Text] [Related]
18. The vasodilator mechanism of sulfur dioxide on isolated aortic rings of rats: Involvement of the K+ and Ca2+ channels.
Zhang Q; Meng Z
Eur J Pharmacol; 2009 Jan; 602(1):117-23. PubMed ID: 19049805
[TBL] [Abstract][Full Text] [Related]
19. 4,5-diphenyltriazol-3-ones: openers of large-conductance Ca(2+)-activated potassium (maxi-K) channels.
Romine JL; Martin SW; Gribkoff VK; Boissard CG; Dworetzky SI; Natale J; Li Y; Gao Q; Meanwell NA; Starrett JE
J Med Chem; 2002 Jul; 45(14):2942-52. PubMed ID: 12086481
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers.
Takahashi T; Koga H; Sato H; Ishizawa T; Taka N; Imagawa J
Bioorg Med Chem; 1998 Mar; 6(3):323-37. PubMed ID: 9568286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
